The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
Open accessAbstract
OBJECTIVE: Despite immune recovery in individuals on combination antiretroviral therapy (CART), the frequency of HIV-associated neurocognitive disorders (HANDs) remains high. Immune recovery is typically achieved after initiation of ART from the nadir, or the lowest historical CD4. The present study evaluated the probability of neuropsychological impairment (NPI) and HAND as a function of CD4 nadir in an HIV-positive cohort. METHODS: One thousand five hundred and twenty-five HIV-positive participants enrolled in CNS HIV Antiretroviral Therapy Effects Research, a multisite, observational study that completed comprehensive neurobehavioral and neuromedical evaluations, including a neurocognitive test battery covering seven cognitive domains. Among impaired individuals, HAND was diagnosed if NPI could not be attributed to comorbidities. CD4 nadir was obtained by self-report or observation. Potential modifiers of the relationship between CD4 nadir and HAND, including demographic and HIV disease characteristics, were assessed in univariate and multivariate analyses. RESULTS: The median CD4 nadir (cells/μl) was 172, and 52% had NPI. Among impaired participants, 603 (75%) had HAND. Higher CD4 nadirs were associated with lower odds of NPI such that for every 5-unit increase in square-root CD4 nadir, the odds of NPI were reduced by 10%. In 589 virally suppressed participants on ART, higher CD4 nadir was associated with lower odds of NPI after adjusting for demographic and clinical factors. CONCLUSION: As the risk of NPI was lowest in patients whose CD4 cell count was never allowed to fall to low levels before CART initiation, our findings suggest that initiation of CART as early as possible might reduce the risk of developing HAND, the most common source of NPI among HIV-infected individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citationHeaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Self-citationLetendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
Self-citationThe prevalence and incidence of neurocognitive impairment in the HAART era
Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., McArthur, J. C., Collier, A. C., Evans, S. R., & Ellis, R. J. (2007) · AIDS · doi:10.1097/qad.0b013e32828e4e27 · Cited by 619
Self-citationTozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R., Galgani, S., Corpolongo, A., Vlassi, C., Larussa, D., Zaccarelli, M., Noto, P., et al. (2005) · Journal of NeuroVirology · doi:10.1080/13550280590952790 · Cited by 130
Valcour, V., Yee, P., Williams, A. E., Shiramizu, B. T., Watters, M. R., Selnes, O. A., Paul, R. H., Shikuma, C., & Sacktor, N. C. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600915339 · Cited by 110
Nadir CD4 Cell Count Predicts Neurocognitive Impairment in HIV-Infected Patients
Muñoz-Moreno, J. A., Fumaz, C. R., Ferrer, M. J., Prats, A., Negredo, E., Garolera, M., Pérez‐Álvarez, N., Moltó, J., Melis, G. G., & Clotet, B. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0310 · Cited by 102
Kalichman, S. C., Rompa, D. J., & Cage, M. (2000) · International Journal of STD & AIDS · doi:10.1258/0956462001916551 · Cited by 90
Cited by
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis
Wang, Y., Liu, M., Lu, Q., Farrell, M., Lappin, J. M., Shi, J., Lu, L., & Bao, Y. (2020) · Neurology · doi:10.1212/wnl.0000000000010752 · Cited by 348
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
For the German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI), Eggers, C., Arendt, G., Hahn, K., Husstedt, I. W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8503-2 · Cited by 339
The Mind Exchange Working Group, Antinori, A., Arendt, G., Grant, I., Letendre, S., Chair, Munoz-Moreno, J. A., Eggers, C., Brew, B., Brouillette, M.-J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis975 · Cited by 208
Self-citationBiomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
Jessen Krut, J., Mellberg, T., Price, R. W., Hagberg, L., Fuchs, D., Rosengren, L., Nilsson, S., Zetterberg, H., & Gisslén, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088591 · Cited by 167
Metadata
- Authors
- Ellis, R. J., Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., Clifford, D., Collier, A. C., Gelman, B., McArthur, J., Morgello, S., McCutchan, J. A., & Grant, I.
- Venue
- AIDS
- Published
- 2011-09-10
- Volume
- 25
- Issue
- 14
- Pages
- 1747-1751
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2066816136
- Cited by
- 411
- References
- 8
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.